BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 6536989)

  • 1. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
    Cattani A; Mahaha D; Michaud P; Rodríguez JA; López JM; García H; Foradori A; Velásquez CG
    Rev Chil Pediatr; 1984; 55(6):374-9. PubMed ID: 6536989
    [No Abstract]   [Full Text] [Related]  

  • 2. [17-hydroxyprogesterone in the diagnosis and treatment of adrenogenital syndrome].
    Cassorla F
    Rev Chil Pediatr; 1982; 53(4):295-304. PubMed ID: 7163538
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
    Lippe BM; LaFranchi SH; Lavin N; Parlow A; Coyotupa J; Kaplan SA
    J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221
    [No Abstract]   [Full Text] [Related]  

  • 5. [A case of congenital adrenogenital syndrome].
    Sumiya H; Kawamura K; Kataumi Z; Fuse H; Ito H; Shimazaki J
    Hinyokika Kiyo; 1985 Aug; 31(8):1433-9. PubMed ID: 3878668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O; Shimura N; Nakayama Y; Arisaka M; Yabuta K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1913-5. PubMed ID: 3197614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood progesterone and 17-hydroxyprogesterone levels and production rates in a boy with virilizing congenital adrenal hyperplasia.
    Strott CA; Yoshimi T; Bardin CW; Lipsett MB
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1085-8. PubMed ID: 5660261
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
    Parth K; Zimprich H; Swoboda W; Brunel R; Bohrn E
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):148-57. PubMed ID: 202131
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome].
    Vavrinec J; Dvorák P; Zizkovský V; Kopecký A; Pospísilová D; Starý J
    Cesk Pediatr; 1983 Sep; 38(9):533-6. PubMed ID: 6315246
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.
    Winterer J; Chrousos GP; Loriaux DL; Cutler GB
    J Pediatr; 1985 Jan; 106(1):137-42. PubMed ID: 3871229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
    Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
    Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to treatment of congenital adrenal hyperplasia in infancy.
    Young MC; Hughes IA
    Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
    Frisch H; Parth K; Schober E; Swoboda W
    Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
    Hughes IA; Winter JS
    J Pediatr; 1976 May; 88(5):766-73. PubMed ID: 1271137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
    Theintz GE; Sizonenko PC
    Arch Fr Pediatr; 1985 Mar; 42(3):211-7. PubMed ID: 4004483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
    Bailey CC; Komrower GM
    Arch Dis Child; 1974 Jan; 49(1):4-7. PubMed ID: 4361889
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
    Solish SB; Goldsmith MA; Voutilainen R; Miller WL
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1148-52. PubMed ID: 2555382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic peptide and fludrocortisone therapy in congenital adrenal hyperplasia.
    Arisaka O; Hosaka A; Arisaka M; Shimura N; Nakayama Y; Yamashiro Y; Yabuta K
    Acta Paediatr; 1992 Mar; 81(3):268-9. PubMed ID: 1387331
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.
    Barnes ND; Atherden SM
    Arch Dis Child; 1972 Feb; 47(251):62-5. PubMed ID: 4336233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
    Job JC; Canlorbe P; Lambertz J; Courouble P; Rossier A
    Ann Pediatr (Paris); 1970; 17(6):426-31. PubMed ID: 5421325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.